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Abstract 
Irreversible brain damage is commonly seen in patients that have suffered strokes, 
cardiac arrest, or other brain ischemia events. The hypoxic conditions result in neuron death, 
and previous studies have shown that additional damage occurs when blood flow is restored. 
It is thought that the lack of energy production during post-ischemia events also causes 
severe brain damage, as the brain heavily depends on oxidative phosphorylation. Cytochrome 
c (Cyt c) plays a crucial role in this energy production by means of the electron transport 
chain (ETC), transferring electrons between complexes ΙΙΙ (cytochrome bc1) and ΙV 
(cytochrome c oxidase, CcO). Mitochondrial release of Cyt c into the cytosol results in type 
ΙΙ apoptosis, and release within the mitochondria results in reduction by superoxides, 
suggesting that Cyt c detoxifies reactive oxygen species (ROS). It is also understood that 
phosphorylation of proteins within the ETC serves a regulation mechanism. We sought to 
determine whether the phosphorylation of a specific tyrosine (Y) residue within Cyt c, Y97, 
affects the binding kinetics between Cyt c and CcO, thus regulating the physiological role of 
Cyt c. We hypothesized that comparison of binding kinetics of mutated Y97E Cyt c and wild 
type Cyt c, both to CcO, in an in vitro study would reveal insight on the effects of 
phosphorylation at this specific residue. The Y97 residue was replaced by a glutamate (E) 
residue− the negative charge from E resembled the negative charge of the phosphate group in 
phosphorylated Cyt c. Both mutant, Y97E, and wild-type, Y97, were synthesized and 
purified, then subjected to analytical ultracentrifuge and laser photolysis in order to examine 
the binding kinetics. Results from both analytical ultracentrifuge and laser photolysis 
revealed little difference in binding between the mutant and the wild-type Cyt c.  
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Introduction and Specific Aims 
Oxidative phosphorylation produces 15 times more adenosine triphosphate (ATP) 
than produced by anaerobic glycolysis. ATP is the primary energy currency of the cell (1) 
and the process by which ATP is generated through oxidative phosphorylation consists of the 
electron transport chain (ETC) and ATP synthase. The electron transport chain, found in the 
inner mitochondrial membrane, is composed of four complexes and two electron carriers: 
NADH dehydrogenase (complex I), succinate dehydrogenase (complex II), ubiquinone, bc-1 
complex (complex III), cytochrome c (Cyt c), and cytochrome c oxidase (complex IV) (2). 
Most electrons enter the ETC via complex I from NADH, which is generated at earlier stages 
of metabolic processes (glycolysis and the citric acid cycle). Complex II is directly connected 
to the citric acid cycle and is the only complex that does not pump protons from the 
mitochondrial matrix to the intermembrane space. The movement of protons generates an 
electrochemical gradient, which is utilized by ATP synthase (complex V). ATP synthase is a 
large protein complex, which synthesizes ATP from adenosine diphosphate (ADP) and 
phosphate by the potential created from the movement of protons.      
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Figure 1. Scheme of the Mitochondrial Electron Transport Chain and Oxidative 
Phosphorylation 
As ATP is a necessary macromolecule for the proper functioning of many organisms, 
Cyt c is a crucial multifunctioning protein. It has a molecular weight of approximately 12,000 
Daltons and is composed of 104 amino acids, with a covalently bound protoporphyrin IX 
heme group. Mammalian Cyt c has two major functions: transfer electrons from complex III 
to complex IVwithin the ETC, and contribution in initiating type 2 apoptosis. Cyt c accepts 
one electron from complex III and transports it to complex IV; this reaction enables the 
reduction of oxygen into water and the production of ATP. The globular protein is one of the 
most positively charged proteins (5). A high number of lysine residues on the globular 
protein surface facilitate interactions with both complexes through electrostatic interactions. 
These interactions have been proven essential in mice after midgestation, as experimentation 
revealed that mortality follows this developmental stage in Cyt c knockout mice. Studies with 
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cultured rat embryos assisted in explaining the finding above- energy production relied 5% 
on aerobic metabolism before gestation day 9 but increased to 95% after gestation day 11 (3).  
 
Figure 2: Human Cytochrome C. Tyrosine 97 is in violet 
Changes of mitochondrial integrity are accompanied with the release of Cyt c into the 
cytosol, which leads to the initiation of type 2 apoptosis (11). Procaspase-9 is activated to 
caspase-9 via an apoptosome in a mechanism that is not fully understood, but it is considered 
that Cyt c is an important proapoptotic signal. The sequence of events that occur in cell death 
as a result of the release of Cyt c are speculated to be: change of respiratory rates, reactive 
oxygen species production, release of Cyt c from the mitochondria, apoptosome 
establishment, and the final caspase activation which triggers apoptosis (2).  
Cyt c has an additional role within the mitochondria, as it participates in another 
reduction-oxidation reaction as a reactive oxygen species (ROS) detoxifying enzyme (4, 18). 
Although oxidative phosphorylation is heavily regulated, mitochondria have been shown to 
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form variable amounts of ROS, producing oxidative stress to the cell. When Cyt c is 
detached from the mitochondrial membrane, it can be reduced by ROS (5). ROS are 
potentially damaging molecules, such as peroxide, superoxide, and hydroxide radical. Aging 
and multiple degenerative diseases have been related to persistent oxidative stress, as both 
high and low levels ROS result in damage of healthy cells (6).  Diseases in which oxidative 
stress has been implicated include multiple sclerosis, diabetes, glaucoma, ischemic-
reperfusion injury, cardiovascular diseases, rheumatoid arthritis, Alzheimer’s disease, 
Parkinson’s disease, and mitochondrial diseases (6).  
 
 
Figure 3: ROS damage is more likely in hyperactive COX (Maik Huttemann et al.  
Biochimica et Biophysica Acta 1817 (2012) 598–609) 
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Additionally, reversible brain damage is commonly seen in patients that have suffered 
strokes, cardiac arrest, or other brain ischemia events. The hypoxic conditions result in 
neuron death and it is thought that the lack of energy production during post-ischemia events 
also causes severe brain damage, as the brain heavily depends on oxidative phosphorylation. 
However, previous studies have shown that additional damage occurs when blood flow is 
restored. This damage, termed reperfusion injury, results from reestablishment of cellular 
energy levels. Following an ischemic starvation phase, mitochondria are rapidly restored 
within five minutes but this hyperactive state results in the overproduction of ROS. As stated 
above, ROS can trigger apoptosis and can lead to initiation of the ETC and secondary energy 
failure (2). 
There are two roles that Cyt c has in ischemia and reperfusion, the loss of Cyt c 
function, thus resulting in secondary energy failure, and initiation of type 2 apoptosis and cell 
death by the release of Cyt c from the mitochondria. (2) The identification of multiple 
phosphorylation sites have lead to the understanding that the phosphorylation of Cyt c is 
reversible and functions as a regulation mechanism, leading to strong enzyme regulation (2, 
4).  It has been found that healthy cells contain phosphorylated Cyt c proteins. In fact, 
isolated Cyt c from ischemic brain were not phosphorylated and could bind to Apaf1 to 
initiate downstream caspase activation. (7) It is possible that phosphorylation can regulate the 
interaction between Cyt c and CcO to further serve as a therapeutic intervention to control 
the amount of damage caused by ischemia/reperfusion. (2)  
With the guidance of Dr. Francis Millett, this project studied the binding interactions 
of Cyt c within the ETC. We sought to determine whether the phosphorylation of a specific 
tyrosine (Y) residue in Cyt c, Y97, affects the binding kinetics between Cyt c and CcO, 
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implying a regulation site for the physiologic role of Cyt c. We hypothesized that the 
comparison of binding kinetics of mutated Y97E Cyt c and wild type Cyt c, both to CcO, in 
an in vitro study would result in understanding the effects of phosphorylation at this specific 
residue. The Y97 residue was replaced by a glutamate (E) residue− the negative charge from 
E resembled the negative charge of the phosphate group in phosphorylated Cyt c. Both 
mutant, Y97E, and wild-type, Y97, were synthesized and purified, then subjected to 
analytical ultracentrifuge and laser photolysis in order to examine the binding kinetics. 
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Methods 
Site-Directed Mutagenesis  
Site-directed mutagenesis was required to obtain plasmids with the desired Cyt c 
mutant sequence, Y97E. This process allows for the sequence of the selected recombinant 
human Cyt c plasmid to be altered by insertion, deletion, or substitution.  
A Stratagene Quik-Change II site-directed mutagenesis was selected to be used for 
this procedure. The tyrosine at position 97 of the wild-type Cyt c, encoded by TAC, was 
changed to a nucleotide sequence of GAG. This codon refers to the amino acid glutamate, 
thus forming the Y97E phosphomimetic sequence. Y97E mutant oligonucleotide sense and 
antisense primers were ordered from Integrated DNA Technologies, Inc.  
 
 
Wild-type 
 
 
5’ GCG GAC CTG ATC GCG TAC CTG AAA AAG GCG ACG 3’ 
Y97E sense primer 5’ GCG GAC CTG ATC GCG GAG CTG AAA AAG GCG ACG 3’ 
Y97E antisense primer 5’ CGT CGC CTT TTT CAG  CTC CGC GAT  CAG GTC  CGC 3’ 
 
Table 1: Wild-type plasmid and sense and antisense primer sequences. Mutated tyrosine 
codon is underlined in the wild-type sequence, and the corresponding glutamate codon is 
underlined and italicized in each primer sequence. 
Upon the arrival of the designed primers, they were placed within a pulse- centrifuge 
(VWR Scientific Model V micro centrifuge) for approximately ten seconds and were 
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suspended in 0.8 mL of sterile, deionized and distilled H!O (ddi). These samples were 
incubated at room temperature for approximately two hours. The primers were placed in a -
20°C freezer until they were ready to be used.  
The primers were allowed to thaw on ice, and a Hewlett- Packard 8452 A Diode 
Array Spectrophotometer was used to determine the concentration of each primer. This 
measurement required that 5 μL of each primer be placed in it’s respective eppendorf tube, 
followed by an addition of 495 μL ddi H!O to each sample. The absorbance readings were 
taken at 260 nm, the peak absorbance for DNA bases. Taking Beer’s Law into account, the 
absorption reading was equal to the extinction coefficient, the length of the cuvette, and the 
concentration. 
Equation 1: A=εcl 
  An extinction coefficient 33 mg mL-1 for single-stranded DNA was used and the 
resulting value for concentration required multiplication by 100, as the dilution was 1:100. 
With 200 µL as the total volume, each stock primer was diluted to 63 µg mL-1.  
Proceeding site-directed mutagenesis, reaction mixtures were made from this final 
dilute stock. Polymerase chain reaction (PCR) technology was used to amplify the number of 
copies of the mutant plasmid. Thin-walled PCR tubes held 50 μL in volume although the 
mass of plasmid contained in each tube varied. The amounts of mutagenesis reagents used 
are indicated in Table 2. Tubes were placed in the thermal cycler and PCR was run according 
to a preset PCR cycling program, Davis preset, which lasted 2 hours and 45 minutes.  
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Table 2: Y97E Cyt c plasmid preparation. 
Tubes were taken out of the thermal cycler and allowed to cool on ice to reach a 
temperature at or below 37 °C. After they have cooled, 1 µL Dpn1 restriction enzyme was 
added to the tubes to digest the parent enzyme and then incubated for an hour at 37 °C. 5 μL 
of the Dpn1- DNA mixture was inserted into a pre-chilled Falcon 2054 polypropylene tube. 
After Epicurian Coli XL-1 Blue supercompetent cells were thawed on ice, 50 μL were added 
to the treated cells and gently mixed. This mixture was incubated on ice for 30 minutes, and 
heat-pulsed at 42 °C for 1 minute. An additional 2 minute incubation on ice followed. 0.5 mL 
of NZY+ broth was added to each tube, and the tubes were incubated at 37 °C for 1 hour 
with shaking (225-250 rpm). The cell mixtures from each tube were spread over a plate 
surface, an LB agar plate containing ampicillin (AMP) antibiotic. AMP on the agar plates 
ensured that only cells with the desired plasmid would be able grow since the Cyt c plasmid 
was engineered to contain a gene for AMP resistance. Plates were placed in an incubator set 
at 37 °C for 48 hours. Proceeding incubation, 3 colonies were aseptically removed from each 
plate and placed into an individual glass culture tube containing 5 mL of NZY+ broth and 5 
µL of AMP (100mg/mL solution). These culture tubes were incubated overnight at 37 °C in a 
rotating shaker. 
Reaction Tube A B 
[Parent plasmid], ng/mL 25 12.5 
Plasmid, μL 28.8 14 
Sense primer, μL 6 6 
Antisense primer, μL 6 6 
10X Pfu reaction buffer, μL 5 5 
dNTP mix, μL 1 1 
Pfu polymerase, μL 1 1 
Sterile H2O, μL 2.2 17 
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Mutant plasmids were prepared and purified for sequencing with a Wizard Miniprep 
DNA Purification System. Broth culture tubes were taken from the rotating incubator and 1.5 
mL- Eppendorf microcentrifuge tubes were labeled to match one of the culture tubes. 1.5mL 
of the cell mixture was removed from the broth culture tubes via pipette and placed into the 
correspondingly labeled Eppendorf tubes using aseptic techniques. Each tube was 
centrifuged for one minute in a microcentrifuge at 10,000 rpm. Afterwards, the resulting 
supernatant was poured off and more cell mixture was added. This procedure was followed 
until all of the cell mixture was pelleted. Supernatant was again poured off, but the remaining 
broth was removed with a pipettor. 400 μL of cell resuspension solution was introduced to 
the pellet, and pipetted up and down until all of the cells were off of the wall and 
resuspended. 400 μL of lysis solution was added and mixed by 4 gentle inversions of the 
tube. The suspension immediately cleared and 400 μL of Neutralization solution was added. 
Again, a gentle mixing was achieved by four inversions, as vortexing the cell solution would 
have caused shearing of the DNA. The cell lysate was centrifuged at 10,000 rpm for 5 
minutes, but it was crucial that a pellet formed or this step would have been repeated until a 
pellet formed. Supernatant was transferred to a 2.5-mL screw-cap Falcon tube with 1 mL of 
resin and mixed by inversion, followed by standing for 5 minutes. 5 mL syringes were 
prepared by removing the plungers, attaching a minicolumn, and transferring the resin and 
lysate mixture in. The mixture was pushed through the minicolumn and 2 mL of column 
wash was then added to again push through the minicolumn. The minicolumn was removed 
from the syringe and placed on an Eppendorf microcentrifuge tube, and then centrifuged at 
10,000 rpm for 2 minutes to dry the resin. The minicolumn was transferred to a new 
Eppendorf microcentrifuge tube, where 50 μL of preheated 70 °C sterile H2O directly on the 
	   14	  
resin, and allowed to sit for one minute. This was centrifuged at 10,000 rpm for 1 minute, the 
flow through from the column now in the Eppendorf tube was labeled and stored at -80 °C. 
To make sure that the prepared plasmids contained the selected mutations, they were 
sent to the DNA Sequencing Laboratory at the University of Arkansas for sequencing. These 
samples for sequencing were prepared from the plasmid preparations. 495 μL of sterile 
ddiH2O and 5 μL of the plasmid preparation, a 1:00 dilution, were placed in a quartz cuvette 
and the concentration of the plasmid was calculated from absorbance measurements. 500 ng 
of plasmid per sample was desired, and so the volume of plasmid needed was calculated. 2.9 
μL of the sequencing primer and plasmid were added to a labeled, sterile 1.5-mL Eppendorf 
tube along with enough sterile ddiH2O to reach a volume of 13 μL. Results from sequencing 
validated that the plasmids did uptake the desired mutations.   
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Transformation with Mutant Plasmid 
The Y97E-only mutant Cyt c plasmid was needed to transform E. coli BL21-DE3 
competent cells. 6 liters of Terrific Broth was prepared and autoclaved. The desired plasmid 
and E.Coli stock from the -80°C freezer were kept on ice until thawed. A Falcon screw-cap 
tube was pre-chilled and 2 μL of the plasmid and 25 μL of E. coli competent cells were 
added. The suspension was gently mixed by pipetting then allowed to incubate on ice for 30 
minutes, followed by 2 minutes of heat-pulsing at 42 °C and then returned to ice for 2 
minutes. After 500 μL of 2xYT broth were added, the mixture was placed in a 37 °C 
incubator for 1 hour. The mixture was spread plated onto a 2xYT+AMP agar plate with a 
overnight incubation. With sterile toothpicks, a colony was aseptically removed from the 
plate and dropped into a 6L Erlenmeyer flasks containing 2 L of sterile Terrific broth with 
2mL of AMP, three toothpicks dropped in each flask. These flasks were placed on orbital 
shakers and incubated at 37 °C for 48 hours.  
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Cytochrome c Purification 
After incubation, harvesting was achieved by centrifuging the cell suspensions in 500 
mL pre-weighed centrifuge bottles in a JA-10 rotor of a Beckman-Coulter Avanti J-A 
preparatory centrifuge at 10,000 rpm for 15 minutes. The resulting supernatant was 
discarded. 3 mL of lysis buffer, containing of 50 mM Tris pH 8, 5 mM EDTA, 10 mM 
magnesium sulfate, and 1 mM calcium chloride, per gram cell paste was added to the cell 
paste. 9 mg of lysozyme was added per gram of paste, as was 32 μL per gram pellet of 50 
mM PMSF in ethanol (phenylmethylsulfonyl fluoride). After stirring in room temperature for 
20 minutes, a few crystals of DNase were added and the mixture was moved to a 37 °C 
incubator to stir for 20 more minutes. Then the mixture was removed from the incubator and 
followed by 1 hour of stirring in room temperature. The mixture was placed in a freezer-
proof container to be stored overnight at -80 °C. The mixture was then thawed and 
centrifuged at 18,000 rpm and 4 °C for 30 minutes, keeping the supernatant. While stirring 
on ice, ammonium sulfate was added to bring the cell lysate to a concentration of 50% 
saturation. After the mixture mixed for 30 minutes it was centrifuged at 18,000 rpm to 
remove large particles. Supernatant was poured off again and ammonium sulfate was added 
to a concentration of 90% saturation at 4 °C. After mixing for 30 minutes on ice, this was 
centrifuged again, but the resulting pellet was kept and the supernatant was discarded. The 
pellet was resuspended with enough water to reintroduce it back into solution. Following was 
an overnight dialysis with a 6,000 – 8,000 MWCO against 5 L of 10mM Tris pH 8.0 at 4°C, 
with one complete buffer change after 4-6 hours. Dialysate was centrifuged to remove any 
precipitate, and then loaded onto a Sephadex S-Sepharose cation-exchange chromatography 
column, which was equilibrated with 50 mM Tris, pH 8. A gradient maker was set up with 
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high and low salt solutions- 50 mM Tris, pH 8, with 500 mM sodium chloride as high and 50 
mM Tris, pH 8, as the low salt solution. Fractions were collected every two minutes using a 
fraction collector. Those fractions with red color, characteristic of Cyt c, were taken to the 
spectrophotometer for absorbance readings- 280 nm (for protein concentration) and 410 nm 
(for the heme group of Cyt c). 
 
 
Figure 4: Example of a characteristic Cyt c absorbance spectrum. Characteristic peaks for 
Cyt c at 416 and 550 nm. 
Fractions with an absorbance reading higher at 410 nm than the readings at 280 nm 
were combined and concentrated to a final volume of 15 mL by placing into a 10,000 
MWCO concentrator at 4,000 rpm, exchanged with 5 mM sodium phosphate (Pi), pH 7.0, to 
reduce the salt concentration and the conductivity of the solution.  
High-pressure liquid chromatography (HPLC) was the final step in purification. On a 
Hitachi LaChrom Elite HPLC system, buffer reservoirs were degassed, Cyt c was oxidized 
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with a small amount of potassium ferricyanide (K3Fe(CN)6), and loaded onto the BioRad 
UNO S12 cation exchange column. 
 
 
Figure 5: Example of an HPLC gradient for purification of Cyt c. 
The diode array detector was set to monitor absorbance at 280 nm, 410 nm, and 542 
nm, with fractions collected by an automated fraction collector. Fractions containing Cyt c 
were again combined and concentrated in a 10,000 MWCO concentrator at 6,000 rpm. These 
were divided into 100 μL aliquots and frozen at -80 °C. 
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Cytochrome c Oxidase Purification 
Purified bovine CcO had previously been prepared in the lab by the same procedure 
described by Capaldi (12).Small aliquots were stored in the -80 °C freezer and a single 
aliquot of CcO was removed from the freezer and thawed on ice for each experiment.  
 
Analytical Ultracentrifugation 
The dissociation constant (Kd) for the binding between Cyt c and CcO was analyzed 
using analytical ultracentrifugation techniques. Ultracentrifugation takes advantage of 
sedimentation coefficients; large proteins or protein complexes have larger sedimentation 
coefficients than small proteins, thus they move outward rapidly. CcO is a much larger 
protein than Cyt c, which results in an even larger complex size when bound together. CcO 
and the Cyt c-CcO complex sediment more rapidly during ultracentriguation than unbound 
Cyt c, and therefore Cyt c remains in solution is separated. This separation allows for the 
concentration of unbound Cyt c in the sample to be measured over several time points to 
calculate Kd.  
Experiments with both wild type and Y97E mutant Cyt c were completed. The 
experiments involved a salt titration, in which several ultracentrifuge runs were performed. 
The initial sample cells contained no salt, and were therefore at low ionic strength, while the 
final cells were at high salt and ionic strength where Cyt c would not bind to CcO.   
The CcO concentration within the ultracentrifuge sample cell was approximately 7 
μM and the concentration of Cyt c was lower, approximately 5 μM, so that CcO was in 
excess. The excess CcO permitted that all of the Cyt c to be bound to CcO at zero salt. 
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Samples were prepared by exchanging CcO with 5 mM Pi, pH 7.4, with 0.2% lauryl 
maltoside, and the concentration of CcO was measured with absorbance readings at 420 – 
460 with an extinction coefficient of 134 mM-1 or 598 minus 630 nm with an extinction 
coefficient of 12.7 mM-1. Cyt c was added by a similar technique, as the concentration was 
also determined spectrophotometrically from absorbance at 410 nm. The ultracentrifuge cell 
contained 300 μL of the prepared sample. Each ultracentrifuge run was approximately 1 hour 
and 15 minutes, at 48,000 rpm and 22 °C. Using a monochromator head, absorbance scans 
were taken every 10 minutes at 410 nm. The salt concentration within the cell was increased 
after each run by adding 2 or 5 M NaCl. The salt concentrations for the ultracentrifuge runs 
were 0, 50, 100, 150, 200, and 350 mM. The concentrations of the last runs were high-salt 
concentrations, with a goal to inhibit nearly all binding of Cyt c to CcO. The resulting data 
was analyzed to determine the Kd value for the protein complex containing wild-type Cyt c or 
mutant Y97E at each salt concentration. 
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Flash Photolysis – Reduction of Ruthenium-39- Cyt c 
 Electron transfer with Cyt c was studied using a previously prepared Ru-39 Horse Cyt 
c, which has the ruthenium complex (Ru(bpy)2(mobpy)) covalently bound to horse Cyt c at a 
constructed Cys-39. The inhibition of electron transfer rate from Ru-horse Cyt c to bovine 
CcO was studied by addition of human Cyt c, both wild type and mutant Y97E.   
 The covalent attachment of the ruthenium complex was prepared by the same methods 
as described by Geren (15). The sacrificial donors for the ruthenium complex were aniline 
and 3CP.  Ionic strength was increased with 5mM phosphate buffer (Pi) pH 7.0 in 0.1% LM, 
by addition of 2M NaCl. Excess salt was removed from CcO with an Amicon concentrator 
with a molecular weight cut off of 100,000 daltons. Reaction solutions contained 5.0 μM 
bovine CcO, 10 μM Ru-39- Cyt c, 5mM phosphate buffer pH 7.0 in 0.1% lauryl maltoside, 
1mM 3CP, 10mM aniline, and varying concentrations of human Cyt c.  Separate experiments 
were conducted for native or mutant Cyt c. The total sample volume was consistently 300 
µL, contained in a 1cm glass or quartz cuvette.  
The concentrations of Ru-39- Cyt c, native or mutant Cyt c, and bovine CcO were 
found using a Hewlett Packard 8452A diode array spectrometer with a UV filter. Flash 
photolysis experiments were conducted as described by Geren et al. (15).  Blanks were taken 
at 600 and 550 nm.  The ruthenium was excited with a Phase R model DL1400 flash lamp-
pumped dye laser producing a 450nm light pulse with <0.5μs duration.   Absorbance 
transients were recorded at 600 and 550 nm, using appropriate time scales.  
Nine trials were conducted for both wild type and mutant Y97E. 10 µM wildtype or 
mutant human Cyt c were added to the sample after the first trial, and the third trial contained 
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an additional 10 µM Human Cyt c for a total of 20 µM Human Cyt c. The fourth trial began 
the salt titrations- increasing the concentration throughout the experiment: 50, 90, 150, 170, 
200, and 350 mM NaCl. 
 After the experiment was completed, Na dithionite was used to reduce the sample for 
final concentration measurements. The equations 2 and 3 were used to calculate the final 
concentration of the ruthenium derivative, native horse Cyt c, native human Cyt c, and 
bovine CcO.   
Equation 2: [Cyt c] = (A550- A442)/ 17.8 
Equation 3: [CcO] = (A605- A630)/33  
The absorbance transients were fitted using the SI fittings program written by Tracy 
Jackson. A 600 nm filter with a 10 nm bandwidth was used to measure the reduction of heme 
a, the extinction coefficient used was Δε604 = 16 mM-1 cm-1 (16).   
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Results and Discussion 
Analytical Ultracentrifugation 
The analytical ultracentrifuge took absorbance scans taken every 10 minutes at 410 
nm at varying radii within the cell. The absorbance data for wild-type Cyt c and the Y97E 
Cyt c can be seen in figures 6 and 7. Data from trials with different salt concentration were 
complied onto a single graph, and the salt concentrations were labeled by color.  Each graph 
contained a spike in absorbance at approximately 6.35 cm, which represents the meniscus of 
the fluid in the sample cell. Data points plateau at approximately 6.5 cm. 
 
 
Figure 6: Analytical ultracentrifuge data for wild-type Cyt c and CcO. 
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Figure 7: Analytical ultracentrifuge data for Y97E Cyt c and CcO. 
The concentration of free Cyt c was calculated by the absorbance at the plateau and 
the absorbance at the baseline radius using Beer’s law. The extinction coefficient was 106 
mM-1 cm-1. Calculations for bound Cyt c required the subtraction of the concentration of free 
Cyt c from the initial concentration of Cyt c within the sample. The concentration of bound 
CcO was equal to the concentration of bound Cyt c because there is 1:1 binding relationship.  
Free CcO within the solution was calculated by subtracting the concentration of bound CcO 
from the original CcO concentration. Determination of the Kd value for each ultracentrifuge 
run could then be solved for using equation 4. Error limits were ± 20 %.   
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Equation 4: Kd = ([Cyt c]free * [CcO]free)  
            [Cyt c*CcO]bound 
Equation 5: [Cyt c]Total = [Cyt c]free + [Cc*CcO]bound 
 
Equation 6: [Cyt c*CcO]bound = [Cyt c]Total - [Cyt c]free 
 
Equation 7: [CcO]Total = [CcO]free + [Cyt c*CcO]bound 
 
Equation 8: [CcO]free = [CcO]Total - [Cyt c*CcO]bound 
 
Results of these calculations for each experiment are shown in Table 3. 
[NaCl] mM Kd for WT Cyt c (µM) Kd for Y97E Cyt c (µM) 
0 <0.2 <0.2 
50 0.5 ± 0.1 0.5 ± 0.1 
100 5.6 ± 1.1 6.1 ± 1.2 
150 31.7 ± 6.3 20.5 ± 4.1 
200 >40 >40 
350 >40 >40 
Table 3: Kd values determined from analytical ultracentrifuge experiments. 
Larger values for Kd indicate that higher concentrations of free protein and lower 
concentrations of bound protein were present in the sample cell.  A significant difference in 
Kd value would suggest that the Cyt c of higher Kd value binds less tightly to CcO than the 
Cyt c with a lower Kd value.  
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Kd values of wild-type Cyt c and the Y97E Cyt c were found to be very similar upon 
comparison, suggesting that phosphorylation at the Y97 residue does not affect binding 
between Cyt c and CcO. 
 
Flash Photolysis – Reduction of Ruthenium-39- Cyt c 
 The electron transfer within the Cyt c -CcO complex was measured utilizing a 
photoactive tris(bipyridine)ruthenium group (Ru(II)) covalently attached to horse Cyt c at 
position 39 (Ru-39- Cyt c). Ru (II) was photoexcited by a laser, inciting a rapid electron 
transfer to the heme in Ru-39-Cyt c. The photo-reduced heme subsequently transferred an 
electron to the CuA in CcO, followed by a transfer to heme a. Rate constants were determined 
by changes of absorbance measurements; increased absorbance at 600 nm is seen when an 
electron is transferred from CuA to heme a.  Next, the electron traveled to CuB and a decrease 
in absorbance is seen at 600 nm due to the oxidation of heme a (13).   
 Human Cyt c and the Ruthenium-39-Cyt c compete for the binding site on CcO.  Salt 
weakens complex binding so that it dissociates.  At low salt, electron transfer from the heme 
of Cyt c to CuA in CcO is observed as the fast phase. An internal electron transfer within CcO 
then occurs - CuA to heme a.  The Cyt c-CcO complex dissociates in the slow phase, seen at 
high salt.  A scheme of the electron transfer is shown in Figure 8.   
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Figure 8: Ru-39- Cyt c.  The laser light strikes Ru. Excitation of Ru results in electron 
transfer, seen by the blue arrows (14). 
 
 
 
Equation	  9:	  Binding	  of	  human	  Cyt	  c	  to	  CcO Equation	  10:	  Binding	  of	  Ru-­‐39-­‐Cyt	  c	  to	  CcO. 	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Figure 9: 5.60uM Bovine CcO. 10.16uM Ru-39-Cyt c. Aniline 10mM. 3CP 1mM. 600nm.  
 
 
 
Figure 10: 5.60uM Bovine CcO. 10.16uM Ru-39-Cyt c. Aniline 10mM. 3CP 1mM. 600nm. 
9.9uM Human WT-Cyt c. 
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Flash photolysis absorbencies are measured at 550 and 600 nm; measuring electron 
transfer to Cyt c at 550nm and electron transfer to CcO heme a measured at 600nm. Rate 
constants at varying ionic strengths were commuted via a computer system.  
 
Table 4: Electron transfer rates with increasing [NaCl]. Flash photolysis, 600 nm transients, 
5.60 uM Ru horse Cyt Cyt c, 20.1 uM WT, 21.2 uM Y97E. 
 
 
 Electron transfer rates of WT human Cyt c were compared to human Y97E.  
Comparison of electron transfer rates between wild-type Cyt c and Y97E Cyt c were very 
similar, and once again led to the conclusion that phosphorylation at the Y97 residue does not 
affect binding between Cyt c and CcO. 
 
Conclusions 
 The phosphomimetic mutant of Cyt c was well expressed. There was no significant 
difference in the binding of WT and mutant Y97E Cyt c to CcO. The results of the ruthenium 
kinetics studies are in Table 4.  The electron transfer rate constants are proportional to the 
rate constant of dissociation of the complex between Cyt c and CcO.  There was no 
significant difference in the rate constant of dissociation for wild-type and mutant Y97E Cyt 
c from CcO. In conclusion, preliminary studies on the effect of the phosphomimetic mutation 
of Cyt c on the electron transfer reaction between Cyt c and CcO have indicated that the 
Y97E mutation does not have an effect on the Km of the reaction or electron transfer rate. 
 
[NaCl] mM 0 50 90 150 170 200 
WT rate (1/s) 52± 10 96± 19 274± 55 322± 64 318± 64 257± 51 
Y97E rate (1/s) 74± 15 88± 18 254± 51 382± 76 316± 63 200± 40 
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